FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / DELIVERY ORDER

PURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT # 75A501

Awarded to GLAXOSMITHKLINE, LLC

PIID 75A50123F61005US · USAspendingOther
$4.7M
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$4,680,601sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateDec 12, 2022
Company legal name
GLAXOSMITHKLINE, LLC
UEI / CAGE
FRHTPHMZMX47 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
Office of Assistant Secretary for Preparedness and Response
Industry
Other
NAICS
541714
PSC
AN12
Performance period
Not reported — Not reported
Recipient address
5 MOORE DR RESEARCH TRIANGLE PK, DURHAM, DURHAM, NC, 27709
Place of performance
MARIETTA, LANCASTER, PA, 17547
Source last modified
Nov 3, 2026

Description

PURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT # 75A50122D00002 2. ADD FUNDING IN THE AMOUNT OF $1,038,708.00 FOR 33 BUL

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    PURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT # 75A501

    US · usaspendingSource ↗
  2. Value increased

    PURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT # 75A501

    US · usaspending$4.7MSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Dec 12, 20220Not reported$4,680,600.50Not reportedNot reportedPURPOSE OF THIS MODIFICATION IS TO: 1. ACCEPT TRANSFER ACCOUNTABILITY OF 5,015,690 VIALS (50.1 MILLION DOSES) OF AS03 ADJUVANT FROM CONTRACT # W15QKN-20-C-0048 TO CONTRACT # 75A50122D00002 2. ADD FUNDING IN THE AMOUNT OF $1,038,708.00 FOR 33 BULUSAspending ↗